We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
BLISSGVS.NSE

Price
119.02
Stock movement up
+2.61 (2.24%)
Company name
Bliss GVS Pharma Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
12.54B
Ent value
14.55B
Price/Sales
1.57
Price/Book
1.20
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
19.77
Forward P/E
-
PEG
-
EPS growth
-9.93%
1 year return
2.25%
3 year return
20.07%
5 year return
2.86%
10 year return
1.06%
Last updated: 2025-04-12

DIVIDENDS

BLISSGVS.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E19.77
Price to OCF90.15
Price to FCF90.15
Price to EBITDA25.52
EV to EBITDA29.62

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales1.57
Price to Book1.20
EV to Sales1.82

FINANCIALS

Per share

Loading...
Per share data
Current share count105.33M
EPS (TTM)5.99
FCF per share (TTM)1.31

Income statement

Loading...
Income statement data
Revenue (TTM)8.00B
Gross profit (TTM)3.03B
Operating income (TTM)1.26B
Net income (TTM)634.20M
EPS (TTM)5.99
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)37.86%
Operating margin (TTM)15.70%
Profit margin (TTM)7.93%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash331.10M
Net receivables4.28B
Total current assets8.51B
Goodwill77.11M
Intangible assets2.72M
Property, plant and equipment0.00
Total assets12.83B
Accounts payable957.54M
Short/Current long term debt941.72M
Total current liabilities1.93B
Total liabilities2.34B
Shareholder's equity10.48B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)139.07M
Capital expenditures (TTM)0.00
Free cash flow (TTM)139.07M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity6.05%
Return on Assets4.95%
Return on Invested Capital5.74%
Cash Return on Invested Capital1.26%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open118.00
Daily high123.81
Daily low118.00
Daily Volume177K
All-time high215.65
1y analyst estimate-
Beta0.90
EPS (TTM)5.99
Dividend per share-
Ex-div date18 Jul 2024
Next earnings date30 Apr 2025

Downside potential

Loading...
Downside potential data
BLISSGVS.NSES&P500
Current price drop from All-time high-44.81%-12.89%
Highest price drop-68.98%-56.47%
Date of highest drop29 Mar 20229 Mar 2009
Avg drop from high-32.88%-11.07%
Avg time to new high66 days12 days
Max time to new high1807 days1805 days
COMPANY DETAILS
BLISSGVS.NSE (Bliss GVS Pharma Limited) company logo
Marketcap
12.54B
Marketcap category
Large-cap
Description
Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India and internationally. The company offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, topical preparations, and transdermal patches. It also provides other healthcare products, such as balms, nasal inhalers, over-the-counter products, petroleum jellies, roll-ons, soaps, sprays, and vaginal washes. In addition, the company offers therapeutic products consisting of analgesics, antacids, anxiolytics, and haematinics; anti-bacterials, antibiotics, anti-diabetics, anti-diarrheals, anti-emetics, antifungals, anti-haemorrhoidals, anti-helmintics, anti-infectives, anti-inflammatories, anti-malarials, anti-microbials, anti-migraines, anti-oxidants, anti-protozoals, anti-pyretics, anti-septics, anti-spasmodics, anti-ulcers, and anti-ulcerants; cough syrups and nasal decongestants; and products for erectile dysfunction, laryngitis, and pharyngitis. Further, it provides and anti-dandruff shampoos, appetizers, hand sanitizers, health and nutritional supplements, insecticides, mosquito repellants, moisturizers, prickly heat powders, skin lightening lotions, vaginal contraceptives, vaginal hygiene products, and vitamin supplements; and amino acid preparations, iron tonics, antitussives, appetite stimulants, anti-allergics, body supplements, ear wax solvents, and oral rehydration products. The company exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.
Employees
831
Investor relations
-
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found